Loading organizations...
Loading organizations...
k16 ventures: Venture capital firm that invests in early-stage startups and supports seed-stage funding rounds for biotech and other tech sectors.
K16 Ventures is a venture capital firm specializing in early-stage startup investments, with a particular focus on the biotech sector. The firm actively participates in seed-stage funding rounds, notably co-investing in Orbillion Bio's $5.0 million seed round on April 1, 2021. K16 Ventures frequently collaborates with a network of co-investors and affiliates, including Astanor Ventures, FTW Ventures, Tet Ventures, and Y Combinator, to support its portfolio companies. Its investment strategy targets innovative companies across life sciences and technology, providing crucial capital for development. The firm's operational model is supported by limited partners and co-investors who contribute to its funding rounds. Founding details for K16 Ventures are not publicly available. Its business model centers on funded through limited partners or co-investors in startup rounds.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2021 | Orbillion Bio | $5.0M Seed | — | Astanor Ventures, FTW Ventures, Tet Ventures, Y Combinator, Ethan Perlstein, Jonghoon Lim, Kris Corzine, At One Ventures, FoundersX Ventures |